MDCX news

Latest 1 stories · newest Nov 4, 2026

MDCX

Medicus Pharma to spin off SkinJect via business combination with SPAC

Medicus Pharma announced a non-binding LOI with a SPAC to combine its subsidiary SkinJect, valuing the entity at $135M, alongside concurrent financing to fund a Gorlin Syndrome study.

M&A Nov 4, 2026 sentiment +0.50 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same MDCX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/MDCX/newsSTART FREE